SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model (Q40023848)
Jump to navigation
Jump to search
scientific article published on 17 January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model |
scientific article published on 17 January 2008 |
Statements
1 reference
SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model (English)
1 reference
Kai Fu
1 reference
Michael J Corbley
1 reference
Lihong Sun
1 reference
Jessica E Friedman
1 reference
Feng Shan
1 reference
James L Papadatos
1 reference
Donald Costa
1 reference
Frank Lutterodt
1 reference
Harry Sweigard
1 reference
Scott Bowes
1 reference
Michael Choi
1 reference
P Ann Boriack-Sjodin
1 reference
Robert M Arduini
1 reference
Dongyu Sun
1 reference
Miki N Newman
1 reference
Xiamei Zhang
1 reference
Jonathan N Mead
1 reference
Claudio E Chuaqui
1 reference
H-Kam Cheung
1 reference
Xin Zhang
1 reference
Mark Cornebise
1 reference
Mary Beth Carter
1 reference
Serene Josiah
1 reference
Juswinder Singh
1 reference
Wen-Cherng Lee
1 reference
Alan Gill
1 reference
Leona E Ling
1 reference
17 January 2008
1 reference
1 reference
Identifiers
1 reference